Athira Pharma Inc. (ATHA)
Athira Pharma Statistics
Share Statistics
Athira Pharma has 39.04M shares outstanding. The number of shares has increased by 1.86% in one year.
| Shares Outstanding | 39.04M |
| Shares Change (YoY) | 1.86% |
| Shares Change (QoQ) | 0.97% |
| Owned by Institutions (%) | 46.58% |
| Shares Floating | 35.7M |
| Failed to Deliver (FTD) Shares | 4.25K |
| FTD / Avg. Volume | 2.08% |
Short Selling Information
The latest short interest is 1.56M, so 4.03% of the outstanding shares have been sold short.
| Short Interest | 1.56M |
| Short % of Shares Out | 4.03% |
| Short % of Float | 4.41% |
| Short Ratio (days to cover) | 2.74 |
Valuation Ratios
The PE ratio is -0.23 and the forward PE ratio is -0.32. Athira Pharma's PEG ratio is 0.01.
| PE Ratio | -0.23 |
| Forward PE | -0.32 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0.5 |
| P/FCF Ratio | -0.23 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Athira Pharma.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.18 |
| Quick Ratio | 4.18 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-3.73M |
| Employee Count | 26 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -89.6% in the last 52 weeks. The beta is 3.06, so Athira Pharma's price volatility has been higher than the market average.
| Beta | 3.06 |
| 52-Week Price Change | -89.6% |
| 50-Day Moving Average | 0.4 |
| 200-Day Moving Average | 1.18 |
| Relative Strength Index (RSI) | 28.21 |
| Average Volume (20 Days) | 204.08K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -100.9M |
| Net Income | -96.94M |
| EBITDA | -100.9M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -2.52 |
Balance Sheet
The company has 48.44M in cash and 1.22M in debt, giving a net cash position of 47.22M.
| Cash & Cash Equivalents | 48.44M |
| Total Debt | 1.22M |
| Net Cash | 47.22M |
| Retained Earnings | -406.15M |
| Total Assets | 58.78M |
| Working Capital | 41.71M |
Cash Flow
In the last 12 months, operating cash flow was -97.17M and capital expenditures -33K, giving a free cash flow of -97.2M.
| Operating Cash Flow | -97.17M |
| Capital Expenditures | -33K |
| Free Cash Flow | -97.2M |
| FCF Per Share | -2.53 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATHA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ATHA is $11.25, which is 4226.9% higher than the current price. The consensus rating is "Hold".
| Price Target | $11.25 |
| Price Target Difference | 4226.9% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
Scores
| Altman Z-Score | -13.78 |
| Piotroski F-Score | 0 |